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It has come to our attention that in our Experimental Procedures we inadvertently omitted a full description of the immu-
nofluorescence staining procedure for Figure 4N. MCF-7 cells shown in Figure 4N were treated with tumor necrosis factor
a (TNFa) (20 ng/ml) for 30 min or left untreated (TNFa) as a negative control. After fixation, the cells were stained with anti-
FOXO3a-pS644 antibody and FITC-labeled secondary antibody. The fluorescence level and cellular localization of endog-
enous FOXO3a-pS644 were assessed by fluorescence analysis under a fluorescent microscope. After fluorescence pic-
tures were taken, the signals on these slides were bleached with a high-intensity laser beam for 2 hr. After bleaching,
the quenched signals were confirmed by fluorescence analysis.
The anti-FOXO3a-pS644 antibody was preincubated with either blocking peptide (DGLDFNFDpSLISTQNVVGL) or control
peptide (DGLDFNFDSLISTQNVVGL) for 30 min at room temperature. The bleached slides were re-stained with the pre-
treated anti- FOXO3a-pS644 antibody, followed by a FITC-labeled secondary antibody. The fluorescence signals on the
same field of cells were recorded as described above. This explains why the upper panel and the lower panel of
Figure 4N appear similar, as the same group of cells was imaged.
To confirm that the same results could be obtained in comparing staining across cells treated on different slides, we per-
formed a peptide competition assay with MCF-7 cells plated on separate slides, which were treated with TNFa or left
untreated, and stained with an anti-FOXO3a-pS644 antibody preincubated with either blocking peptide or control peptide,
followed by a FITC-labeled secondary antibody. The fluorescence level and cellular localization of endogenous
FOXO3a-pS644 were assessed by fluorescence analysis. As shown in Figure 1, the same result could be obtained with
this approach.
The conclusions in our paper remain the same, and we apologize if this lack of clarity has caused any inconvenience.Cell 129, 1427–1428, June 29, 2007 ª2007 Elsevier Inc. 1427
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